Advertisement

Topics

ISIS Papyrus Software Company Profile

15:37 EDT 25th June 2019 | BioPortfolio


News Articles [362 Associated News Articles listed on BioPortfolio]

Syrian fighting escalates as US targets last Isis stronghold – The Times

Syrian fighting escalates as US targets last Isis stronghold The TimesISIS reduced to only '500 fighters hiding in just five square miles' Mirror OnlineUS-backed Syrian forces launch attack on final...

Biotronik launches PK Papyrus covered coronary stent in US

More than 800,000 percutaneous coronary intervention procedures are performed annually in the US3 and fewer than 8,000 require a covered stent, classifying PK Papyrus as a Humanitarian Use The post B...

Isis caliphate ‘reduced to just 700 square metres’ as US-backed forces close in on last enclave in Syria – The Independent

Isis caliphate 'reduced to just 700 square metres' as US-backed forces close in on last enclave in Syria The IndependentMilitants using civilians as human shields delay capture of final IS enclave Ba...

Clinical Trials of Isis 2503 Anticancer Compound Initiated

Isis Pharmaceuticals (Carlsbad, CA) has initiated a Phase II clinical trial of Isis 2503, its third antisense anticancer compound in clinical development...

BIOTRONIK Launches PK Papyrus Covered Coronary Stent in the US

Isis Innovation: How the Oxford Sciences Innovation fund is promoting investment in the Oxfordshire region

Adam Stoten, head of Technology Transfer at Isis Innovation (the technology transfer arm of the University of Oxford) discusses the recent successes of Oxford Sciences Innovation (OSI), a fund compris...

Daily briefing: Chemist sent mercenaries to save her PhD student from ISIS

The caliphate is a hellscape of smoke and fire – Isis has nowhere left to go – The Guardian

The caliphate is a hellscape of smoke and fire – Isis has nowhere left to go The Guardian'Decisive battle' to defeat Islamic State taking place in Baghouz Sky NewsISIS zealots face final assault a...

PubMed Articles [294 Associated PubMed Articles listed on BioPortfolio]

Providing healthcare under ISIS: A qualitative analysis of healthcare worker experiences in Mosul, Iraq between June 2014 and June 2017.

During ISIS occupation of the Northern Iraqi city of Mosul between June 2014 to June 2017, healthcare workers remaining in Mosul continued to provide medical services. Little is currently known about ...

Stomach contents of the archaeocete Basilosaurus isis: Apex predator in oceans of the late Eocene.

Apex predators live at the top of an ecological pyramid, preying on animals in the pyramid below and normally immune from predation themselves. Apex predators are often, but not always, the largest an...

Can scalar timing explain variability in scanning patterns?

Why are scanning patterns so variable? Theory predicts that for prey species facing non-stalking predators scans to monitor predators should occur at fixed rather than unpredictable times. Yet, empiri...

Adaptation and spectral enhancement at auditory temporal perceptual boundaries - Measurements via temporal precision of auditory brainstem responses.

In human and animal auditory perception the perceived quality of sound streams changes depending on the duration of inter-sound intervals (ISIs). Here, we studied whether adaptation and the precision ...

Scientific Community Image Forum: A discussion forum for scientific image software.

Forums and email lists play a major role in assisting scientists in using software. Previously, each open-source bioimaging software package had its own distinct forum or email list. Although each pro...

Clinical Trials [686 Associated Clinical Trials listed on BioPortfolio]

A Double Blind, Placebo-Controlled, Dose-Escalation, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ISIS 353512 Administered Intravenously and Subcutaneously to Healthy Volunteers

The purpose of this study is to evaluate the safety and tolerability of single and multiple doses of ISIS 353512, to evaluate the blood concentration and rate elimination of ISIS 353512 fr...

Dose-Escalating Safety Study in Subjects on Stable Statin Therapy

The aim of this study is to assess the safety of varying doses of ISIS 301012 in subjects on Stable statin therapy.

Study of ISIS 301012 in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

The aim of this study is to assess the safety and efficacy of varying doses of ISIS 301012 as add-on therapy in subjects with Heterozygous Familial Hypercholesterolemia

The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes

To evaluate the efficacy and safety of ISIS 2922 in AIDS patients with Cytomegalovirus ( CMV ) retinitis who are unresponsive or intolerant to ganciclovir and/or foscarnet but are otherwis...

A Study of Multiple Doses of ISIS SMNRx (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

The primary objective of the study is to examine the efficacy of multiple doses of ISIS SMNRx (ISIS 396443) administered intrathecally in preventing or delaying the need for respiratory in...

Companies [1154 Associated Companies listed on BioPortfolio]

ISIS Papyrus Software

Isis Innovation

Isis Innovation is the technology transfer company of the University of Oxford, commercialising the research generated by University researchers and owned by the University.Isis Innovation Ltd is a wh...

Isis Parenting Inc.

Isis Parenting is the nation’s leading provider of prenatal and early parenting education. Isis partners with leading healthcare institutions to offer over their patients ove...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. is a leading drug discovery and development company, focused exclusively on the therapeutic target, RNA. Founded in 1989, Isis' mission is to develop products from its RNA-b...

More Information about "ISIS Papyrus Software" on BioPortfolio

We have published hundreds of ISIS Papyrus Software news stories on BioPortfolio along with dozens of ISIS Papyrus Software Clinical Trials and PubMed Articles about ISIS Papyrus Software for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ISIS Papyrus Software Companies in our database. You can also find out about relevant ISIS Papyrus Software Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record